Integrase-defective lentiviral vectors: progress and applications
- PMID: 19847206
- DOI: 10.1038/gt.2009.135
Integrase-defective lentiviral vectors: progress and applications
Abstract
Lentiviral vectors (LVs) offer the advantages of a large packaging capacity, broad cell tropism or specific cell-type targeting through pseudotyping, and long-term expression from integrated gene cassettes. However, transgene integration carries a risk of disrupting gene expression through insertional mutagenesis and may not be required for all applications. A non-integrating LV may be beneficial in cases in which transient gene expression is desired. Several recent publications outline the development and initial biological characterization of such vectors. Here, we discuss the potential applications and new directions for the development of integration-defective LVs.
Similar articles
-
Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.Gene Ther. 2005 Jul;12(14):1089-98. doi: 10.1038/sj.gt.3302570. Gene Ther. 2005. PMID: 16003340 Review.
-
Integrase defective, nonintegrating lentiviral vectors.Methods Mol Biol. 2010;614:101-10. doi: 10.1007/978-1-60761-533-0_6. Methods Mol Biol. 2010. PMID: 20225038
-
Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors.Genesis. 2009 Apr;47(4):217-23. doi: 10.1002/dvg.20469. Genesis. 2009. PMID: 19208434
-
Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors.Gene Ther. 2009 Apr;16(4):509-20. doi: 10.1038/gt.2008.186. Epub 2009 Jan 22. Gene Ther. 2009. PMID: 19158847
-
Lentiviral vectors: are they the future of animal transgenesis?Physiol Genomics. 2007 Oct 22;31(2):159-73. doi: 10.1152/physiolgenomics.00069.2007. Epub 2007 Aug 7. Physiol Genomics. 2007. PMID: 17684037 Review.
Cited by
-
A p21 reporter iPSC line for evaluating CRISPR-Cas9 and vector-induced stress responses.Stem Cells. 2024 Nov 5;42(11):992-1005. doi: 10.1093/stmcls/sxae056. Stem Cells. 2024. PMID: 39283950 Free PMC article.
-
The Crosstalk Analysis between mPSCs and Panc1 Cells Identifies CCN1 as a Positive Regulator of Gemcitabine Sensitivity in Pancreatic Cancer Cells.Int J Mol Sci. 2024 Aug 29;25(17):9369. doi: 10.3390/ijms25179369. Int J Mol Sci. 2024. PMID: 39273316 Free PMC article.
-
Emerging trends in virus and virus-like particle gene therapy delivery to the brain.Mol Ther Nucleic Acids. 2024 Jul 19;35(3):102280. doi: 10.1016/j.omtn.2024.102280. eCollection 2024 Sep 10. Mol Ther Nucleic Acids. 2024. PMID: 39206077 Free PMC article. Review.
-
Advances in HIV Gene Therapy.Int J Mol Sci. 2024 Feb 28;25(5):2771. doi: 10.3390/ijms25052771. Int J Mol Sci. 2024. PMID: 38474018 Free PMC article. Review.
-
Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells.Pharmaceutics. 2023 Oct 13;15(10):2459. doi: 10.3390/pharmaceutics15102459. Pharmaceutics. 2023. PMID: 37896219 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources